Celcuity Inc
Clinical trials sponsored by Celcuity Inc, explained in plain language.
-
New combo aims to outperform current standard in advanced breast cancer
Disease control Recruiting nowThis Phase 3 study tests whether adding the experimental drug gedatolisib to standard hormone therapy and palbociclib can delay cancer growth better than the current standard treatment (hormone therapy plus ribociclib) in people with HR-positive, HER2-negative advanced breast can…
Phase: PHASE3 • Sponsor: Celcuity Inc • Aim: Disease control
Last updated Jun 27, 2026 12:34 UTC
-
New drug duo takes on Hard-to-Treat prostate cancer
Disease control Recruiting nowThis study tests two drugs—gedatolisib and darolutamide—together in men with metastatic castration-resistant prostate cancer (mCRPC), a type that has spread and no longer responds to standard hormone therapy. The first part finds the safest dose, and the second checks if the comb…
Phase: PHASE1, PHASE2 • Sponsor: Celcuity Inc • Aim: Disease control
Last updated Jun 27, 2026 12:06 UTC